You are here

Antares Pharma

Biopharma takeout spend ticks up

EP Vantage

Tue, 07/5/22 - 11:02 am

Bristol Myers Squibb

Turning Point Therapeutics

Sierra Oncology

Halozyme Therapeutics

Halozyme Picks Up Antares' Drug Delivery Tech for Nearly $1B

BioSpace

Wed, 04/13/22 - 10:53 am

Halozyme Therapeutics

Bucking the trend, Antares gains FDA OK for testosterone rejection on second try

Endpoints

Tue, 10/2/18 - 10:05 am

Pfizer Is Keeping Details of New 'Rescue Pen' Low Key, for Now

Medical Devices and Diagnostics Industry

Wed, 08/8/18 - 09:24 am

QuickShot autoinjector

drug development

Teva and Antares Pharma Announce Launch of Generic Imitrex® in the United States

Yahoo

Mon, 06/27/16 - 09:35 am

Teva Pharmaceutical

Antares Pharma announces notice of allowance for new patent

The Fly on the Wall

Fri, 12/20/13 - 08:45 am

Antares Pharma Announces the Issuance of a New U. S. Patent for OTREXUP™

Yahoo/BusinessWire

Fri, 06/28/13 - 12:24 pm

A Deep Dive Into Antares Pharma's Buyout Thesis

Seeking Alpha

Wed, 03/27/13 - 09:58 am

3 Things to Watch With Antares Pharma

Motley Fool

Wed, 11/21/12 - 10:39 am

Antares Pharma Announces Positive Results from Final MTX Medi-Jet™ Clinical Study

Tue, 11/13/12 - 10:08 pm

clinical trials

Antares Pharma aims to raise $47M from stock sale

Wed, 10/3/12 - 10:21 pm

Reconsidering Zalicus And Antares In Light Of Shakeups

Seeking Alpha

Wed, 10/3/12 - 10:56 am

Antares Pharma says it will sell stock to raise research funds; gets $750K payment from Pfizer

Yahoo/AP

Wed, 10/3/12 - 10:47 am

Antares Pharma Announces Successful Results from VIBEX MTX Actual Human Use Study

Tue, 09/25/12 - 09:04 pm

Antares Pharma Reports Second Quarter 2012 Financial and Operating Results

Thu, 08/9/12 - 12:44 am

Antares Pharma Announces Positive Results from VIBEX MTX Usability Study

Tue, 06/26/12 - 10:27 pm

Antares Pharma Announces Move to the NASDAQ Stock Market

Wed, 06/6/12 - 11:27 pm

Antares Pharma Reports First Quarter 2012 Financial and Operating Results

Tue, 05/8/12 - 08:59 pm

Watson, Antares launch Gelnique 3% for overactive bladder treatment

Pharmabiz

Sat, 04/28/12 - 01:40 pm

Watson Pharmaceuticals

overactive bladder

Antares Pharma and Boston Scientific Look to Make Headway in Surging Medical Supplies Industry

Thu, 03/22/12 - 09:05 pm

Boston Scientific

Pages